Heberlig Chris

CIK 00015322173 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001532217

Recent Transactions

50 trades

Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2020-09-15+20,000→ 20,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2019-09-17+50,000→ 50,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2019-03-04+46,000→ 46,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2018-09-20+45,000→ 45,000 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class B Common Shares
2018-05-29+74,935→ 440,920 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series A Preferred Shares
2018-05-29−74,935→ 0 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-05-29−6,392→ 0 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Shares
2018-05-29+6,392→ 42,991 total
Purchase
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-02-09$15.64/sh+6,392→ 6,392 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−7,500→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−82→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−12,500→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−12,000→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−838→ 0 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-22$78.87/sh+56→ 24,446 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-22−446→ 24,000 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-22−24,000→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−5,000→ 0 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-05+24,000→ 24,390 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$103.55/sh−3,290→ 2,200 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$76.88/sh+86→ 390 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$40.74/sh+7,500→ 7,890 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$100.44/sh−900→ 6,990 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$104.57/sh−1,510→ 690 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$105.74/sh−300→ 390 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2015-03-11−7,500→ 7,500 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$102.46/sh−900→ 5,490 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-03-11$101.38/sh−600→ 6,390 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$92.10/sh−1,156→ 604 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$89.90/sh−1,800→ 4,604 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$93.04/sh−300→ 304 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-12-29−5,000→ 5,000 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-12-29−1,100→ 838 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$1.70/sh+1,100→ 1,404 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$23.00/sh+5,000→ 6,404 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-12-29$91.34/sh−2,844→ 1,760 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-06-30$54.89/sh+112→ 304 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-03-12−5,000→ 10,000 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$0.95/sh+820→ 2,862 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$99.08/sh−3,037→ 192 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$23.00/sh+5,000→ 7,862 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$98.49/sh−3,933→ 3,229 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-03-12−1,850→ 1,938 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$1.70/sh+1,850→ 2,042 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-03-12$96.75/sh−700→ 7,162 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-03-12−820→ 0 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2013-12-31$36.30/sh+192→ 192 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2013-07-16$48.26/sh−2,029→ 0 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2013-07-15$0.95/sh+1,877→ 2,524 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2013-07-15$49.15/sh−495→ 2,029 total

Companies

Recent Filings

Address

SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520

LEXINGTON, MA, 02421

View on SEC.gov